Top

Cardiovascular Intervention and Therapeutics

Published in:

01-01-2020 | Intravascular Ultrasound | Expert consensus document

Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics

Authors: Yuichi Saito, Yoshio Kobayashi, Kenichi Fujii, Shinjo Sonoda, Kenichi Tsujita, Kiyoshi Hibi, Yoshihiro Morino, Hiroyuki Okura, Yuji Ikari, Junko Honye

Published in: Cardiovascular Intervention and Therapeutics | Issue 1/2020

Abstract

Intravascular ultrasound (IVUS) provides precise anatomic information in coronary arteries including quantitative measurements and morphological assessment. To standardize the IVUS analysis in the current era, this expert consensus document summarizes the methods of measurements and assessment of IVUS images.

di Mario C, Koskinas KC, Raber L. Clinical benefit of IVUS guidance for coronary stenting: the ULTIMATE step toward definitive evidence? J Am Coll Cardiol. 2018;72:3138–41.PubMed

Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T, et al. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. Eurointervention. 2011;6:1123–30.PubMed

Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2001;37:1478–92.PubMed

Lockwood GR, Ryan LK, Hunt JW, Foster FS. Measurement of the ultrasonic properties of vascular tissues and blood from 35 to 65 MHz. Ultrasound Med Biol. 1991;17:653–66.PubMed

Okada K, Kitahara H, Mitsutake Y, Tanaka S, Kimura T, Yock PG, et al. Assessment of bioresorbable scaffold with a novel high-definition 60 MHz IVUS imaging system: comparison with 40 MHz IVUS referenced to optical coherence tomography. Catheter Cardiovasc Interv. 2018;91:874–83.PubMed

Yamada R, Okura H, Kume T, Hayashida A, Neishi Y, Kawamoto T, et al. Comparison of quantitative measurements between two different intravascular ultrasound systems: in vitro and in vivo studies. J Cardiol. 2013;61:201–5.PubMed

Li Y, Honye J, Saito S, Takayama T, Yokoyama S, Saruya T, et al. Variability in quantitative measurement of the same segment with two different intravascular ultrasound systems: in vivo and in vitro studies. Catheter Cardiovasc Interv. 2004;62:175–80.PubMed

ten Hoff H, Korbijn A, Smith TH, Klinkhamer JF, Bom N. Imaging artifacts in mechanically driven ultrasound catheters. Int J Cardiovasc Imaging. 1989;4:195–9.

Hernandez-Sabate A, Gil D, Fernandez-Nofrerias E, Radeva P, Marti E. Approaching artery rigid dynamics in IVUS. IEEE Trans Med Imaging. 2009;28:1670–80.PubMed

10.

Arbab-Zadeh A, DeMaria AN, Penny WF, Russo RJ, Kimura BJ, Bhargava V. Axial movement of the intravascular ultrasound probe during the cardiac cycle: implications for three-dimensional reconstruction and measurements of coronary dimensions. Am Heart J. 1999;138:865–72.PubMed

11.

Morino Y, Tamiya S, Masuda N, Kawamura Y, Nagaoka M, Matsukage T, et al. Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. Circ J. 2010;74:1609–16.PubMed

12.

Raber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European association of percutaneous cardiovascular interventions. Eur Heart J. 2018;39:3281–300.PubMed

13.

Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 1999;34:651–9.PubMed

14.

Lockwood GR, Ryan LK, Gotlieb AI, Lonn E, Hunt JW, Liu P, et al. In vitro high resolution intravascular imaging in muscular and elastic arteries. J Am Coll Cardiol. 1992;20:153–60.PubMed

15.

Kume T, Okura H, Fukuhara K, Koyama T, Yamada R, Neishi Y, et al. Visualization of coronary plaque vasa vasorum by intravascular ultrasound. JACC Cardiovasc Interv. 2013;6:985.PubMed

16.

Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026–34.PubMed

17.

McDaniel MC, Douglas JS Jr. Stent area by intravascular ultrasound and outcomes in left main intervention with drug-eluting stents: small stents, more events. Circ Cardiovasc Interv. 2011;4:542–4.PubMed

18.

Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43:1959–63.PubMed

19.

Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110:3424–9.PubMed

20.

Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5.PubMed

21.

Okura H, Morino Y, Oshima A, Hayase M, Ward MR, Popma JJ, et al. Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study. J Am Coll Cardiol. 2001;37:1031–5.PubMed

22.

Okura H, Kobayashi Y, Sumitsuji S, Terashima M, Kataoka T, Masutani M, et al. Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome. Am J Cardiol. 2009;103:791–5.PubMed

23.

Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, et al. Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial. J Am Coll Cardiol. 2015;66:495–507.PubMed

24.

Pasterkamp G, Borst C, Gussenhoven EJ, Mali WP, Post MJ, The SH, et al. Remodeling of de novo atherosclerotic lesions in femoral arteries: impact on mechanism of balloon angioplasty. J Am Coll Cardiol. 1995;26:422–8.PubMed

25.

Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, et al. Comparison of neointimal hyperplasia and peri-stent vascular remodeling after implantation of everolimus-eluting versus sirolimus-eluting stents: intravascular ultrasound results from the EXCELLENT study. Int J Cardiovasc Imaging. 2013;29:1229–36.PubMed

26.

Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314–22.PubMedPubMedCentral

27.

Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2010;106:1561–5.PubMed

28.

Wu X, Maehara A, Mintz GS, Kubo T, Xu K, Choi SY, et al. Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes. Am J Cardiol. 2010;105:48–53.PubMed

29.

Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2006;47:734–41.PubMed

30.

Hibi K, Kozuma K, Sonoda S, Endo T, Tanaka H, Kyono H, et al. A randomized study of distal filter protection versus conventional treatment during percutaneous coronary intervention in patients with attenuated plaque identified by intravascular ultrasound. JACC Cardiovasc Interv. 2018;11:1545–55.PubMed

31.

Kearney P, Erbel R, Rupprecht HJ, Ge J, Koch L, Voigtlander T, et al. Differences in the morphology of unstable and stable coronary lesions and their impact on the mechanisms of angioplasty. An in vivo study with intravascular ultrasound. Eur Heart J. 1996;17:721–30.PubMed

32.

Honye J, Saito S, Takayama T, Yajima J, Shimizu T, Chiku M, et al. Clinical utility of negative contrast intravascular ultrasound to evaluate plaque morphology before and after coronary interventions. Am J Cardiol. 1999;83:687–90.PubMed

33.

Johnson TW, Raber L, di Mario C, Bourantas C, Jia H, Mattesini A, et al. Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European association of percutaneous cardiovascular interventions. Eur Heart J. 2019. https://doi.org/10.1093/eurheartj/ehz332.CrossRefPubMedPubMedCentral

34.

Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054–61.PubMed

35.

Fujii K, Kobayashi Y, Mintz GS, Takebayashi H, Dangas G, Moussa I, et al. Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation. 2003;108:2473–8.PubMed

36.

Xu Y, Mintz GS, Tam A, McPherson JA, Iniguez A, Fajadet J, et al. Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from providing regional observations to study predictors of events in the coronary tree (PROSPECT). Circulation. 2012;126:537–45.PubMed

37.

Sakamoto K, Nagamatsu S, Yamamoto E, Kaikita K, Tsujita K. Atherosclerotic coronary plaque development visualized by in vivo coronary imaging. Circ J. 2018;82:1727–34.PubMed

38.

Qiu F, Mintz GS, Witzenbichler B, Metzger DC, Rinaldi MJ, Duffy PL, et al. Prevalence and clinical impact of tissue protrusion after stent implantation: an ADAPT-DES intravascular ultrasound substudy. JACC Cardiovasc Interv. 2016;9:1499–507.PubMed

39.

Hong MK, Park SW, Lee CW, Kang DH, Song JK, Kim JJ, et al. Long-term outcomes of minor plaque prolapsed within stents documented with intravascular ultrasound. Catheter Cardiovasc Interv. 2000;51:22–6.PubMed

40.

Okuya Y, Saito Y, Sakai Y, Ishibashi I, Kobayashi Y. Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging. 2019;35:401–7.PubMed

41.

Sotomi Y, Suwannasom P, Tenekecioglu E, Collet C, Nakatani S, Okamura T, et al. Imaging assessment of bioresorbable vascular scaffolds. Cardiovasc Interv Ther. 2018;33:11–22.PubMed

42.

Castagna MT, Mintz GS, Ohlmann P, Kotani J, Maehara A, Gevorkian N, et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005;111:1148–52.PubMed

43.

Badano LP, Miglioranza MH, Edvardsen T, Colafranceschi AS, Muraru D, Bacal F, et al. European association of cardiovascular imaging/cardiovascular imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Eur Heart J Cardiovasc Imaging. 2015;16:919–48.PubMed

44.

St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of “angiographically silent” intimal thickening. Circulation. 1992;85:979–87.PubMed

Title: Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics
Authors: Yuichi Saito
Yoshio Kobayashi
Kenichi Fujii
Shinjo Sonoda
Kenichi Tsujita
Kiyoshi Hibi
Yoshihiro Morino
Hiroyuki Okura
Yuji Ikari
Junko Honye
Publication date: 01-01-2020
Publisher: Springer Japan
Keyword: Intravascular Ultrasound
Published in: Cardiovascular Intervention and Therapeutics / Issue 1/2020
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-019-00625-6

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese Association of Cardiovascular Intervention and Therapeutics

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

Utility of computed tomography in cases of aortic valve stenosis before and after transcatheter aortic valve implantation

Significance of echocardiographic evaluation for transcatheter aortic valve implantation

Intravascular ultrasound guidance improves patient survival (mortality) after drug-eluting stent implantation: review and updated bibliography

Edge restenosis of a polytetrafluoroethylene-covered stent in the superficial femoral artery: insights from an imaging assessment with an electronic high-resolution angioscope

Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective

Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page